Year
Edition number
№8 / 2022
Reviews
Soldatova E.E., Kan N.E., Tyutyunnik V.L., Volochaeva M.V.
Fetal growth retardation in the context of fetal programming5-10
Perminova S.G., Belova I.S., Mityurina E.V., Savostina G.V.
Current approaches to diagnosing and managing female poor responders to ovarian stimulation with gonadotropins in assisted reproductive technology programs12-21
Chernukha G.E., Pronina V.A., Priputnevich T.V.
Gut and genital microbiota in endometriosis22-29
Yakushevskaya O.V., Babaeva N.A., Yureneva S.V., Ashrafyan L.A.
Impact of menopausal hormone therapy on the development and progression of cervical and endometrial cancers30-35
Solopova A.E., Ukraintsev N.I., Rubtsova N.A.
Magnetic resonance imaging in the initial staging of cervical cancer: updating the 2021 ESUR guidelines36-46
Original Articles
Translated to English
Baev O.R., Prikhodko A.M., Ziganshina M.M., Evgrafova A.V., Khomyakova E.V.
Antenatal and intrapartum risk factors associated with fetal hypoxia in labor47-53
Translated to English
Yakubova D.I., Ignatko I.V., Megrabyan A.D., Bogomazova I.M.
The course of pregnancy and childbirth outcomes in different fetal growth restriction phenotypes54-62
Translated to English
Kinsht D.A., Marinkin I.O., Soboleva M.K.
Antenatal and intrapartum periods in singleton pregnancy after assisted reproductive technology63-70
Translated to English
Farzalieva A.V., Sotnikova N.Yu., Borzova N.Yu.
CD163 positive alternatively activated monocytes as a marker of early miscarriage71-75
Translated to English
Altukhova O.B., Radzinsky V.E., Polyakova I.S., Sirotina S.S., Batlutskaya I.V., Orlova V.S., Efremova O.A., Churnosov M.I.
The role of chemokine genes in the development of adenomyosis with concurrent endometrial hyperplastic processes76-84
Translated to English
Fedorova T.A., Krechetova L.V., Bakuridze E.M., Rogachevsky O.V., Zaitsev V.Ya., Strelnikova E.V., Pyregov A.V., Kozachenko I.F., Esayan R.M., Khamidulina K.G., Inviyaeva E.V., Vtorushina V.V., Chudzhaeva E.B.
Systemic ozone therapy and its immunomodulatory effects in COVID-19 patients85-94
Translated to English
Sukhikh G.T., Smulevich A.B., Stenyaeva N.N., Nemenov D.G., Prilepskaya V.N., Khritinin D.F., Myasoedov N.F., Matskevich A.A., Andreeva L.A., E.V. Zelenina E.V.
Orenetide for the treatment of hypoactive sexual desire disorder: results of a randomized placebo-controlled trial95-106
Translated to English
Krogh-Jensen O.A., Nikitina I.V., Bragina O.N., Isaeva E.L., Priputnevich T.V., Zubkov V.V., Degtyarev D.N., Lenyushkina A.A.
Body surface cultures in preterm neonates on the first day of life: clinical usefulness108-123
Exchange of Experience
Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D.
A comprehensive approach to treating chronic recurrent uncomplicated cystitis during pregnancy124-130
Dobrokhotova Yu.E., Borovkova E.I., Zaidieva Z.S., Romanovskaya V.V., Nugumanova O.R.
Assessing the feasibility of preoperative preventive vaginal cleansing to prevent contamination of the uterine cavity with vaginal microflora132-142
Tapilskaya N.I., Gzgzyan А.М., Kоgan I.Yu., Pisarev V.V., Merkulov М.Е., Korneeva I.E.
Pharmacokinetic properties and safety assessment of the generic vaginal gel progesterone preparation: results of an open-label, randomized, crossover bioequivalence study144-152
Guidelines for the Practitioner
Yarmolinskaya M.I., Rusina E.I., Semenova V.O., Beganova A.K.
Extragenital endometriosis: diagnostic difficulties, modern treatment policy154-162
Clinical Notes
Tskhay V.B., Mikailly T.K., Andreeva A.A.
Combined modified two-stage Osada–Strassmann surgery in a patient with severe concurrent pathology (a complete bicornuate uterus, diffusive adenomyosis, and deep infiltrating endometriosis)163-169
Strizhakov A.N., Ignatko I.V., Bogomazova I.M., Belousova V.S., Grigoryan I.S., Korchagina M.O.
Isolated torsion of the fallopian tube during pregnancy170-175
Mirzakhmetova D.D., Khoroshilova I.G., Aipeisova A.Zh., Bogach M.A., Efimenko I.G.
Asphyxiating thoracic dysplasia (Jeune syndrome)176-180
